SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
BMRA

Biomerica Inc (NASDAQ:BMRA)

US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
$1.08-$0.02 (-1.82%)
 
Market cap
$4.97M
Insider Score
Health Score
Analyst consensus
Listed since
Sep 7, 1984
Market Cap$4.97M-51.6%
Revenue (ttm)$4.34M-11.2%
Net Income-$5.01M-37.0%
EPS-$1.63-481.3%
Shares Out4.60M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,382
Open$1.08
Previous Close$1.10
Day's Range$1.06 - $1.10
52-Week Range$1.01 - $2.94
Beta0.31
AnalystsBuy
Price Targetn/a
Earnings DateJan 8, 2027
-3.64% (1D)
No price history available.

About BMRA

Biomerica, Inc. is a biomedical technology firm that invents, secures intellectual property for, produces, and globally distributes diagnostic and therapeutic solutions aimed at identifying and addressing a range of medical conditions and diseases. The company's diagnostic testing kits analyze patient samples, such as blood, urine, or stool, to pinpoint various illnesses and health complications. These kits are also capable of quantifying minute concentrations of specific substances like bacteria, hormones, antibodies, antigens, or other compounds present in bodily fluids or waste. Biomerica primarily sells its products for gastrointestinal disorders, food sensitivities, diabetes, and a variety of specialized diagnostic evaluations. Its distribution channels include physicians' clinics, retail pharmacies, and hospital/clinical laboratories. The company is currently developing InFoods, a diagnostic-guided therapy technology for irritable bowel syndrome; products for Helicobacter pylori; and comprehensive diagnostic tools for COVID-19, encompassing their development, testing, validation, and sale. Established in 1971, Biomerica, Inc. maintains its corporate headquarters in Irvine, California.

Address
17571 Von Karman Avenue, Irvine, CA, 92614, US
Market Cap
5 million
Employees
50
Industrial Classification
Medical - Devices

Biomerica Inc Stock Analysis — InsiderScore

Insider Score
See top-rated InsiderScore stocks ›
61st Percentile Overall Score
BMRA InsiderScore:76 / 99

Biomerica Inc scored higher than 61% of companies evaluated by InsiderBuying, and ranked 20th out of 47 stocks in the healthcare sector.

Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.

Dollars Committed

Insiders at Biomerica Inc bought $158.0K of stock across 5 purchases in the last 90 days, the largest of them $50.0K.

Stake Increase

The average purchase added about 39% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.

New Positions

Every buyer already held stock, so each purchase is an increase rather than a first position.

This category carries 35% of the Insider Score.

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$158.00K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Weak
From BMRA’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-1.82%
5 Days
-22.30%
1 Month
-36.84%
6 Months
-55.74%
1 Year
-51.57%

$BMRA stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in BMRA holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by BMRA's directors and management

Net Shares Purchased by Insiders−100k−50k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

BMRA Estimated quarterly lobbying spending

Source: U.S. Senate LDA

BMRA Revenue by Segment or Geography

BMRA's latest filing doesn't break out revenue by segment.

As of: Q3 2026 (Aug 31, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New BMRA patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to BMRA from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in BMRA

VXFVanguard Extended Market ETF$24.82K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from BMRA’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
100% of score
81.32
Analyst Ratings
No data yet
—
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
5
Sells
0
Buy Value
$158.00K
Distinct Buyers
5

Insider Score Trend Over Time

-17.0 since Sep 23
0255075100Sep 23 — Insider Score 88.9Sep 24 — Insider Score 88.6Sep 25 — Insider Score 93.2Sep 26 — Insider Score 93.0Sep 27 — Insider Score 93.0Sep 28 — Insider Score 93.0Sep 29 — Insider Score 92.7Sep 30 — Insider Score 92.5Oct 1 — Insider Score 92.4Oct 2 — Insider Score 55.0Oct 3 — Insider Score 92.6Oct 4 — Insider Score 92.5Oct 5 — Insider Score 92.5Oct 6 — Insider Score 92.3Oct 7 — Insider Score 92.1Oct 8 — Insider Score 91.9Oct 9 — Insider Score 91.7Oct 10 — Insider Score 91.6Oct 11 — Insider Score 91.8Oct 12 — Insider Score 91.9Oct 13 — Insider Score 91.6Oct 14 — Insider Score 91.6Oct 15 — Insider Score 91.6Oct 16 — Insider Score 91.5Oct 17 — Insider Score 91.3Oct 18 — Insider Score 91.4Oct 19 — Insider Score 91.3Oct 20 — Insider Score 91.3Oct 21 — Insider Score 91.1Oct 22 — Insider Score 91.1Oct 23 — Insider Score 91.0Oct 24 — Insider Score 91.0Oct 25 — Insider Score 90.7Oct 26 — Insider Score 90.7Oct 27 — Insider Score 90.7Oct 28 — Insider Score 90.7Oct 29 — Insider Score 90.5Oct 30 — Insider Score 89.8Oct 31 — Insider Score 89.7Nov 1 — Insider Score 89.7Nov 2 — Insider Score 89.8Nov 3 — Insider Score 89.3Nov 4 — Insider Score 88.9Nov 5 — Insider Score 88.0Nov 6 — Insider Score 87.4Nov 7 — Insider Score 87.2Nov 8 — Insider Score 87.5Nov 9 — Insider Score 87.6Nov 10 — Insider Score 86.7Nov 11 — Insider Score 86.1Nov 12 — Insider Score 85.5Nov 13 — Insider Score 84.4Nov 14 — Insider Score 84.2Nov 15 — Insider Score 84.3Nov 16 — Insider Score 83.9Nov 17 — Insider Score 82.5Nov 18 — Insider Score 75.2Nov 19 — Insider Score 73.8Nov 20 — Insider Score 72.8Nov 21 — Insider Score 71.9Sep 23Oct 22Nov 21

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.